首页 | 本学科首页   官方微博 | 高级检索  
     

多囊卵巢综合征患者身体成分分析的临床价值
引用本文:周文杰,浦丹华,陶新城,从静,常小霞,夏静,吴洁. 多囊卵巢综合征患者身体成分分析的临床价值[J]. 生殖医学杂志, 2020, 0(3): 349-353
作者姓名:周文杰  浦丹华  陶新城  从静  常小霞  夏静  吴洁
作者单位:1.南京医科大学第一附属医院/江苏省人民医院江苏省妇幼保健院
基金项目:江苏省妇幼保健重点学科项目(FXK201701)
摘    要:
目的通过对多囊卵巢综合征(PCOS)患者进行身体成分分析,评判患者的体型、脂肪分布及营养状况,为PCOS患者的健康管理及并发症的预防提供依据。方法收集2018年6月至2019年8月在江苏省人民医院妇科内分泌门诊就诊的PCOS患者123例为PCOS组,选择同期就诊、月经正常的女性121例为对照组。记录所有研究对象的年龄、身高、体重等参数,采用人体成分分析仪(InBody S10),以生物电阻抗法为原理进行相关指标的测定。比较两组对象一般情况及检测指标的差异,并根据BMI进一步行分层分析。结果两组对象年龄、身高、体重比较均无统计学差异(P均>0.05),PCOS组的BMI[(27.14±4.60)vs.(25.82±4.58)kg/m2]、全身脂肪含量[(26.55±8.67)vs.(24.23±8.36)kg]、内脏脂肪面积[(100.37±29.98)vs.(92.40±29.34)cm2]和体脂率[(37.03±6.69)%vs.(35.23±7.06)%]均显著高于对照组(P均<0.05)。根据BMI数值进行分层,当BMI&l...

关 键 词:多囊卵巢综合征  人体成分分析  体脂  肥胖

Clinical value of body composition analysis in patients with polycystic ovary syndrome
ZHOU Wen-jie,PU Dan-hua,TAO Xin-cheng,CONG Jing,CHANG Xiao-xia,XIA Jing,WU Jie. Clinical value of body composition analysis in patients with polycystic ovary syndrome[J]. Journal of Reproductive Medicine, 2020, 0(3): 349-353
Authors:ZHOU Wen-jie  PU Dan-hua  TAO Xin-cheng  CONG Jing  CHANG Xiao-xia  XIA Jing  WU Jie
Affiliation:(The First Affiliated Hospital of Nanjing Medical University/Jiangsu Province Hospital,Jiangsu Women and Children Health Hospital,Nanjing 210029)
Abstract:
Objective:To evaluate the body shape,fat distribution and nutritional status by the body composition analysis in patients with polycystic ovary syndrome(PCOS)to provide a basis for health management and prevention of complications in PCOS patients.Methods:A total of 123 PCOS patients in the Gynecological Endocrine Clinic of Jiangsu Province Hospital as PCOS group from June 2018 to August 2019 were collected as PCOS group,and 121 women with normal menstruation were selected as the control group.The age,height,weight and other parameters of all subjects were recorded.The body composition analyzer(Inbody S10)was used to measure the body composition based on the bioelectrical impedance method.The general condition and detection index were compared between the two groups,and further stratified analysis according to BMI was carried out.Results:There was no significant difference in age,height and weight between the two groups(P>0.05),but BMI[(27.14±4.60)vs.(25.82±4.58)kg/m^2]and body fat content[(26.55±8.67)vs.(24.23±8.36)kg],visceral fat area[(100.37±29.98)vs.(92.40±29.34)cm^2]and body fat ratio[(37.03±6.69)%vs.(35.23±7.06)%]of PCOS patients were significantly higher than those of the control group(P<0.05).Further stratified analysis according to BMI values,the PCOS patients with BMI<24 kg/m^2 had significantly higher body fat content[(15.86±4.71)vs.(13.13±3.39)kg],visceral fat area[(64.65±19.67)vs.(55.09±13.96)cm^2]and body fat ratio[(29.10±5.84)%vs.(25.31±4.82)%]comparing with the control group(P<0.05),but there was no significant difference in extracellular water content,skeletal muscle and bone mineral content between the two groups(all P>0.05).The body fat content[(29.85±6.73)vs.(27.89±5.91)kg]and visceral fat area[(111.39±23.28)vs.(104.71±21.64)cm^2]in the PCOS patients with BMI≥24 kg/m^2 were also significantly higher than those in control group(P<0.05).No significant difference was found in body fat ratio,extracellular water rate,skeletal muscle and bone mineral content between the two groups(P>0.05).Conclusions:PCOS patients have a higher incidence of overweight and obesity,especially abdominal obesity.Regardless of whether the weight of PCOS patients are normal or not,body fat mass and visceral fat area are significantly higher than normal women.Therefore,it is recommended that body fat index and other tests should be performed to better guide clinical nutrition and exercise management and improve body fat distribution and proportion,in order to improve clinical symptoms and prevent long-term complications in PCOS patients.
Keywords:PCOS  Body composition analysis  Body fat mass  Obesity
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号